In LY3039478 24 trials, there were fewer than two AF events in either treatment group; of these, 11 trials (34.4%) did not have any reported events of AF. Results for atrial fibrillation without including atrial flutter were similar, with only five events on alendronate and three events on Thiazovivin Placebo attributed to atrial flutter alone (data not shown). Fig. 1 Relative risk (RR) of all events (A) or serious events (B) of atrial fibrillation or flutter in placebo-controlled trials of alendronate conducted by Merck. Study 51.1 is the vertebral fracture cohort of FIT, and study 51.2 is the clinical fracture cohort of FIT. 0.00 indicates that there were no AF events in the alendronate arm and at least one AF event in the placebo arm Table 2 Odds ratio RG7112 ic50 (expressed as alendronate versus placebo) of atrial fibrillation or atrial flutter by study and treatment arm Study

Treatmenta N Person-years History of atrial fibrillation or atrial flutter n (%) All events n (%) Serious events n (%) Odds ratio of all events Odds ratio of serious events 026 Alendronate 94 140.06 0 (0.00)

0 (0.00) 0 (0.00) Undefined Undefined 026 Placebo 31 51.75 0 (0.00) 0 (0.00) 0 (0.00)     029 Alendronate 265 605.31 0 (0.00) 0 (0.00) 0 (0.00) Undefined Undefined 029 Placebo 90 213.28 0 (0.00) 0 (0.00) 0 (0.00)     035 Alendronate 286 753.89 1 (0.35) 0 (0.00) 0 (0.00) Undefined Undefined 035 Placebo 192 512.44 0 (0.00) 0 (0.00) 0 (0.00)     037 Alendronate 311 826.88 0 (0.00) 1 (0.32) 0 (0.00) Undefined Undefined 037 Placebo 205 540.85 1 (0.49) 0 (0.00) 0 (0.00)     038 Alendronate 235 254.52 0 (0.00) Fossariinae 0 (0.00) 0 (0.00) Undefined Undefined 038 Placebo 56 85.34 0 (0.00) 0 (0.00) 0 (0.00)     041 Alendronate 140 258.57 0 (0.00) 1 (0.71) 0 (0.00) Undefined Undefined 041 Placebo 71 130.48 0 (0.00) 0 (0.00) 0 (0.00)     51.1 Alendronate 1,022 2,719.89 12 (1.17) 27 (2.64) 17 (1.66) 1.16 1.40 51.1 Placebo 1,005 2,638.61 11 (1.09) 23 (2.29) 12 (1.19)     51.2 Alendronate 2,214 8,357.86 19 (0.86) 57 (2.57) 31 (1.40) 1.15 1.56 51.2 Placebo 2,218 8,430.05 20 (0.90) 50 (2.25) 20 (0.90)     054 Alendronate 93 155.70 0 (0.00) 0 (0.00) 0 (0.00) 0.00 0.00 054 Placebo 91 163.85 0 (0.00) 2 (2.20) 2 (2.20)     055 Alendronate 498 1,548.97 1 (0.20) 1 (0.20) 0 (0.00) Undefined Undefined 055 Placebo 502 1,914.93 0 (0.00) 0 (0.00) 0 (0.00)     057 Alendronate 59 132.70 0 (0.00) 1 (1.69) 1 (1.69) Undefined Undefined 057 Placebo 60 128.51 1 (1.67) 0 (0.00) 0 (0.00)     063 Alendronate 32 59.